We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleWhat a solid day it’s been for the ASX today, with the benchmark maintaining a strong run past +1.1%...
Read ArticleICS Global (ICS) asks shareholders to reject an off-market takeover bid by Dawney & Co’s subsidi...
Read ArticleThe ASX will open higher this morning, defying a slump in New York Tesla shares plunged 12% Oil pri...
Read ArticleNZX-listed investment company Dawney & Co is getting ready to lob a bid for ASX-listed peer ICSG...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleThe ASX finished the day slightly down despite Airtasker’s (ASX:ART) positive debut. The Aussie tech...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleThe ICSGlobal Ltd (ASX: ICS) share price has leapt up 13% today after the company provided a positi...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleHere’s our monthly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap he...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleAustralian health care sector is growing potentially by generating significant profits in a short pe...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
